RDA Financial Network Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

RDA Financial Network reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,622 shares of the healthcare conglomerate’s stock after selling 244 shares during the period. UnitedHealth Group makes up 1.6% of RDA Financial Network’s holdings, making the stock its 12th biggest position. RDA Financial Network’s holdings in UnitedHealth Group were worth $5,041,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Watershed Private Wealth LLC boosted its position in shares of UnitedHealth Group by 22.6% during the 3rd quarter. Watershed Private Wealth LLC now owns 1,406 shares of the healthcare conglomerate’s stock worth $822,000 after purchasing an additional 259 shares during the period. Zhang Financial LLC boosted its position in shares of UnitedHealth Group by 18.1% during the 3rd quarter. Zhang Financial LLC now owns 667 shares of the healthcare conglomerate’s stock worth $390,000 after acquiring an additional 102 shares in the last quarter. Occidental Asset Management LLC boosted its position in shares of UnitedHealth Group by 4.9% in the 3rd quarter. Occidental Asset Management LLC now owns 6,997 shares of the healthcare conglomerate’s stock valued at $4,091,000 after purchasing an additional 328 shares during the period. Iams Wealth Management LLC raised its position in UnitedHealth Group by 9.7% in the 3rd quarter. Iams Wealth Management LLC now owns 2,147 shares of the healthcare conglomerate’s stock valued at $1,255,000 after purchasing an additional 189 shares during the last quarter. Finally, Creative Planning raised its position in UnitedHealth Group by 11.0% during the 3rd quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock worth $123,025,000 after buying an additional 21,114 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH traded down $47.59 during trading on Tuesday, reaching $557.81. The company’s stock had a trading volume of 10,778,757 shares, compared to its average volume of 3,944,671. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The firm has a 50 day moving average price of $584.39 and a 200 day moving average price of $532.15. The firm has a market capitalization of $515.09 billion, a price-to-earnings ratio of 37.34, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the company posted $6.14 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 1st. TD Cowen upped their target price on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Truist Financial lifted their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Robert W. Baird boosted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Finally, Royal Bank of Canada upped their target price on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $617.37.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.